PMID: 8605279Jan 1, 1996Paper

Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b

Annals of Hematology
R WeideK H Pflüger

Abstract

Osteoporosis is frequently seen in systemic mastocytosis. Although diphosphonate therapy has been shown to be transiently effective, therapy options for this form of osteopenia are very limited. We have treated three patients with systemic mastocytosis and osteopenia successfully with interferon alpha-2b. Two patients had urticaria pigmentosa and two severe back pain due to vertebral compression fractures. All patients received a daily interferon dose of 3 x 5 mio units/week s.c. for a period of 6 months. Therapy was well tolerated, and back pain resolved in both patients. A marked decrease of mast cell numbers in the bone marrow and a significant increase of bone mineralization and bone density was observed in all patients. Our data suggest that alpha interferon may be a new treatment option for osteopenia in systemic mastocytosis.

Citations

Dec 25, 2004·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·H StänderR Brehler
Dec 23, 2003·Leukemia Research·Ayalew Tefferi
May 30, 2001·Leukemia Research·P ValentJ M Bennett
Nov 23, 2007·The Cancer Journal·Animesh Pardanani, Srdan Verstovsek
Feb 20, 2016·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M RossiniD Gatti
Apr 22, 2014·Immunology and Allergy Clinics of North America·Maurizio RossiniDavide Gatti
Sep 27, 2012·Hematology/oncology Clinics of North America·Animesh Pardanani
Jan 5, 2002·The Journal of Investigative Dermatology. Symposium Proceedings·K HartmannB M Henz
Aug 26, 2006·Immunology and Allergy Clinics of North America·Joseph H Butterfield
Aug 26, 2006·Immunology and Allergy Clinics of North America·Peter Valent
Aug 26, 2006·Immunology and Allergy Clinics of North America·Todd M WilsonJamie Robyn
May 31, 2013·American Journal of Hematology·Animesh Pardanani
Mar 29, 2011·American Journal of Hematology·Animesh Pardanani
Feb 18, 2015·American Journal of Hematology·Animesh Pardanani
Jun 26, 2004·Pathologie-biologie·J SimonUNKNOWN Group AFIRMM (Association française pour les initiatives de recherche sur le mastocyte et les mastocytoses)
Sep 19, 2015·Clinical Lymphoma, Myeloma & Leukemia·Douglas TremblayJohn Mascarenhas
Jun 20, 2006·Best Practice & Research. Clinical Haematology·A PardananiP Valent
Jul 26, 2000·Hematology/oncology Clinics of North America·A S Worobec
May 31, 2016·Reviews in Endocrine & Metabolic Disorders·Loren Wissner GreeneCem Akin
Oct 21, 2016·American Journal of Hematology·Animesh Pardanani
Dec 29, 2004·Leukemia & Lymphoma·Peter ValentDean D Metcalfe
Feb 2, 2006·International Archives of Allergy and Immunology·Nataliya M Kushnir-SukhovDean D Metcalfe
Jun 30, 2009·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Darrin L WillinghamDavid J Kramer
Dec 11, 2002·British Journal of Haematology·Philippe CasassusOlivier Lortholary
Aug 22, 2003·British Journal of Haematology·Peter ValentDean D Metcalfe
Oct 21, 2004·American Journal of Hematology·Bryan HennessySrdan Verstovsek
Mar 14, 2012·American Journal of Hematology·Animesh Pardanani
Jun 4, 2015·Expert Review of Hematology·Sarah FarmerHenrik Frederiksen
Aug 16, 2006·Molecular and Cellular Biochemistry·Junwon LeeNacksung Kim
Jun 1, 1997·Journal of Internal Medicine·C HübnerW Stremmel
Oct 15, 2021·Experimental Biology and Medicine·Shivaani KirankumarJohnson Rajasingh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.